Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2157 POSTS 0 COMMENTS

https://psynews.com

PT261 – Dr. Tiago Reis Marques – Ketamine, New Drugs, and...

Psychedelic Bulletin: DEA Proposes Increase to Psilocybin Quota; Field Trip Launches...

PTSF75 – Possession Limits, Religion, and Scalability

Optimi Health Joins First Psychedelic Exchange Traded Fund

Ian Burnstein Joins Wesana Health Advisory Board

Silo Wellness Announces Approval for Trading on the OTCQB Under Symbol...

Active vs. Passive Coping Distinguishes Antidepressants and Psychedelics

Psychedelic Research Bulletin: June 2021

PsyBio Therapeutics Augments Intellectual Property Portfolio with Filing of Next Novel...

Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc.

1...198199200...216 Page 199 of 216

Psychedelic Alpha’s Top 11 Stories from 2024

Rethinking Addiction and Treatment Models: Is the Recovery Community Ready for...

Psychedelics Today Gifting Guide 2024

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin